Source: Annual Congress 2002 - Lung disposition clinical outcomes: effect of delivery device
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. W. Nagel, S. L. Bates, J. P. Mitchell (London, Canada). In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate. Eur Respir J 2002; 20: Suppl. 38, 3127

Member's Comments

No comment yet.

Related content which might interest you: In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002 Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC) Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008 Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Medication delivery via infant and child valved holding chambers (VHCs) with facemask is aided with inhalation flow indicator Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations Source: Eur Respir J 2006; 28: Suppl. 50, 713s Year: 2006 In vitro comparison of the effect of inhalation delay on the variability of the delivered dose from valved holding chambers Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012 Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery Source: Eur Respir J 2001; 18: Suppl. 33, 494s Year: 2001 Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Delivery of an HFA-formulated bronchodilator to the mechanically ventilated adult patient via holding chamber: laboratory simulation Source: Eur Respir J 2003; 22: Suppl. 45, 473s Year: 2003 Delivery of inhaled glucocorticoids to ventilated and non-ventilated neonates: in vitro model experiments with novel small volume holding chambers Source: Eur Respir J 2002; 20: Suppl. 38, 559s Year: 2002 In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use. Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006 In vitro delivery of budesonide from 10 jet nebulisers using a child breathing pattern Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007